Optimal management of oropharyngeal and esophageal candidiasis in patients living with HIV infection

Optimal management of oropharyngeal and esophageal candidiasis in patients living with HIV infection

Jose A VazquezDivision of Infectious Diseases, Henry Ford Hospital, Wayne State University School of Medicine, Detroit, MI, USAAbstract: Mucocutaneous candidiasis is frequently one of the f irst signs of human immunodeficiency virus (HIV) infection. Over 90% of patients with AIDS will develop oropha...

Full description

Bibliographic Details
Main Author:	Jose A Vazquez
Format:	Article
Language:	English
Published:	Dove Medical Press 2010-04-01
Series:	HIV/AIDS : Research and Palliative Care
Online Access:	http://www.dovepress.com/optimal-management-of-oropharyngeal-and-esophageal-candidiasis-in-pati-a4325

Similar Items

Oropharyngeal candidiasis in HIV/AIDS patients and non-HIV subjects in the Southeast of Iran
by: Samira Salari, et al.
Published: (2018-12-01)

Oropharyngeal Candidiasis (OPC) in hiv infected patients and its antifungal susceptiblity pattern by disc diffusion method
by: P. Chaudhary, et al.
Published: (2020-12-01)

The Changing Epidemiology of Oropharyngeal Candidiasis in Patients with HIV/AIDS in the Era of Antiretroviral Therapy
by: Payal K. Patel, et al.
Published: (2012-01-01)

Role of posaconazole in the treatment of oropharyngeal candidiasis
by: Voichita Ianas, et al.
Published: (2010-06-01)

Ellagic acid: an alternative for antifungal drugs resistance in HIV/AIDS patients with oropharyngeal candidiasis
by: Satutya Wicaksono, et al.
Published: (2020-10-01)

Specific protease mutation patterns are associated with oropharyngeal candidiasis in a New Orleans patient cohort of HIV-infected individuals
by: Peter J. Hickman, et al.
Published: (2015-11-01)

Molecular Typing of Candida Albicans Isolates Recovered from Human Immunodeficiency Virus (HIV)-Infected Patients with Oropharyngeal Candidiasis
by: Farzad Katiraee, et al.
Published: (2014-03-01)

Spectrum and the In Vitro Antifungal Susceptibility Pattern of Yeast Isolates in Ethiopian HIV Patients with Oropharyngeal Candidiasis
by: Birhan Moges, et al.
Published: (2016-01-01)

Profile of candidiasis in HIV infected patients
by: P Anwar-Khan, et al.
Published: (2012-12-01)

Management of oropharyngeal candidiasis with localized oral miconazole therapy: efficacy, safety, and patient acceptability
by: Cookinham S, et al.
Published: (2011-07-01)

Oropharyngeal Candidiasis in HIV Infection: Analysis of Impaired Mucosal Immune Response to Candida albicans in Mice Expressing the HIV-1 Transgene
by: Louis de Repentigny, et al.
Published: (2015-06-01)

Features of the Course of the Upper Gastrointestinal Tract Pathology in Patients with Oropharyngeal Candidiasis
by: I.V. Kushnirenko
Published: (2016-04-01)

Oropharyngeal Candidiasis as a Presenting Symptom of Crohn’s Disease
by: Muhammad Sharif, et al.
Published: (2020-04-01)

Oropharyngeal Candidiasis: Fungal Invasion and Epithelial Cell Responses.
by: Marc Swidergall, et al.
Published: (2017-01-01)

Oropharyngeal candidiasis in children with lymphohematopoietic malignancies in Mashhad, Iran
by: Fariba Berenji, et al.
Published: (2015-03-01)

Predicting and evaluating outcome in oropharyngeal candidiasis (OPC) in AIDS
by: Hood, Stephen Victor
Published: (2000)

Species distribution and <it>in vitro </it>antifungal susceptibility of oral yeast isolates from Tanzanian HIV-infected patients with primary and recurrent oropharyngeal candidiasis
by: Rijs Antonius JMM, et al.
Published: (2008-08-01)

OROPHARYNGEAL MANIFESTATIONS IN HIV INFECTED PATIENTS
by: Gabriela Juganariu, et al.
Published: (2011-04-01)

Esophageal candidiasis and its diagnosis
by: Raghav Bansal, et al.
Published: (2020-02-01)

Oropharyngeal Candidosis in HIV-Infected Patients—An Update
by: Shankargouda Patil, et al.
Published: (2018-05-01)

Evaluation of efficacy and safety of itraconazole oral solution for the treatment of oropharyngeal candidiasis in AIDS patients
by: Queiroz-Telles Flávio, et al.
Published: (2001-01-01)

Oropharyngeal candidiasis and resistance to antifungal drugs in patients receiving radiation for head and neck cancer
by: Maryam Rad, et al.
Published: (2012-07-01)

Evaluation of efficacy and safety of itraconazole oral solution for the treatment of oropharyngeal candidiasis in AIDS patients
by: Flávio Queiroz-Telles, et al.

Oropharyngeal candidiasis and resistance to antifungal drugs in patients receiving radiation for head and neck cancer
by: Maryam Rad DMD, MSc, et al.
Published: (2012-04-01)

Emergence of Azoles Resistance Candida species in Iranian AIDS defined patients with oropharyngeal candidiasis
by: Farzad Katiraee, et al.
Published: (2015-09-01)

Designing Fast-Dissolving Orodispersible Films of Amphotericin B for Oropharyngeal Candidiasis
by: Dolores R. Serrano, et al.
Published: (2019-08-01)

Comparative Efficacy of Antifungal Agents Used in the Treatment of Oropharyngeal Candidiasis among HIV-Infected Adults: A Systematic Review and Network Meta-Analysis
by: Shamala Gopal Rajadurai, et al.
Published: (2021-08-01)

Biofilm-Producing Candida Species Causing Oropharyngeal Candidiasis in HIV Patients Attending Sukraraj Tropical and Infectious Diseases Hospital in Kathmandu, Nepal
by: Lamichhane K, et al.
Published: (2020-06-01)

A study on speciation and antifungal susceptibility pattern of Candida isolates from HIV patients with oropharyngeal candidiasis and correlation with CD4 count
by: Kalpanadevi V, et al.
Published: (2012-05-01)

Candida isolates causing refractory or recurrent oropharyngeal candidiasis in 11 hospitals in China
by: Yu SY, et al.
Published: (2019-04-01)

Neutrophils Do Not Express IL-17A in the Context of Acute Oropharyngeal Candidiasis
by: Anna R. Huppler, et al.
Published: (2015-07-01)

Beta-Defensin 3-Mediated Regulation of Transcriptional Changes During Oropharyngeal Candidiasis
by: White, Cole Jacob
Published: (2018)

The Aryl Hydrocarbon Receptor Governs Epithelial Cell Invasion during Oropharyngeal Candidiasis
by: Norma V. Solis, et al.
Published: (2017-03-01)

Esophageal candidiasis among a dyspeptic population
by: Al Mofleh Ibrahim, et al.
Published: (1999-01-01)

Diagnosis and Treatment of Esophageal Candidiasis: Current Updates
by: Abdimajid Ahmed Mohamed, et al.
Published: (2019-01-01)

Genotyping Analysis of Candida albicans Strains Isolated from Neutropenic Patients during Recurrent Oropharyngeal Candidiasis
by: Ayşegül ESKİTÜRK, et al.
Published: (1997-03-01)

Candida glabrata Binding to Candida albicans Hyphae Enables Its Development in Oropharyngeal Candidiasis.
by: Swetha Tati, et al.
Published: (2016-03-01)

The Dysbiosis and Inter-Kingdom Synergy Model in Oropharyngeal Candidiasis, a New Perspective in Pathogenesis
by: Martinna Bertolini, et al.
Published: (2019-09-01)

The Role of Antimicrobial Peptide Murine Beta Defensin-3 in Protection against Oropharyngeal Candidiasis
by: Mengesha, Bemnet Gashawbeza
Published: (2017)

Risk factors for oral candidiasis in Brazilian HIV-infected adult patients
by: Mariela Dutra Gontijo Moura, et al.
Published: (2015-11-01)